C
TXG icon

Covestor’s 10x Genomics TXG Stock Holding History

Covestor’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26K Sell
690
-18
-3% -$472 0.02% 1090
2026
Q1 		$15K Sell
708
-887
-56% -$17.7K 0.01% 1242
2025
Q4 		$26K Sell
1,595
-180
-10% -$2.72K 0.01% 1174
2025
Q3 		$21K Sell
1,775
-510
-22% -$6.65K 0.01% 1259
2025
Q2 		$26K Buy
2,285
+1,909
+508% +$17.4K 0.02% 1155
2025
Q1 		$3K Buy
376
+1
+0.3% +$13 ﹤0.01% 1806
2024
Q4 		$5K Sell
375
-867
-70% -$13.7K ﹤0.01% 1734
2024
Q3 		$28K Sell
1,242
-4
-0.3% -$83 0.02% 1091
2024
Q2 		$24K Buy
1,246
+199
+19% +$5.21K 0.02% 1144
2024
Q1 		$39K Buy
1,047
+873
+502% +$38.4K 0.02% 977
2023
Q4 		$10K Sell
174
-1
-0.6% -$44 0.01% 1602
2023
Q3 		$7K Sell
175
-3
-2% -$156 0.01% 1644
2023
Q2 		$10K Sell
178
-137
-43% -$7.42K 0.01% 1465
2023
Q1 		$18K Sell
315
-1
-0.3% -$47 0.02% 1045
2022
Q4 		$12K Buy
316
+131
+71% +$4.28K 0.01% 1256
2022
Q3 		$5K Buy
185
+5
+3% +$190 ﹤0.01% 1514
2022
Q2 		$8K Buy
180
+101
+128% +$5.24K 0.01% 1296
2022
Q1 		$6K Sell
79
-138
-64% -$12.1K ﹤0.01% 1465
2021
Q4 		$32K Buy
+217
New +$33.2K 0.04% 738

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Covestor's TXG Position: Q2 2026 in Review

Covestor reduced its 10x Genomics (TXG) stake by 2.5% in Q2 2026, selling an estimated $472 and leaving 690 shares worth $26K. The position accounts for 0.02% of the portfolio, ranked #1090.

Covestor first reported a position in TXG in Q4 2021 and has held it in 19 quarters since. The position peaked at $39K in Q1 2024. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Covestor held 690 shares of 10x Genomics worth $26K as of Q2 2026.
  • Covestor sold 18 10x Genomics shares in Q2 2026, an estimated $472.
  • 10x Genomics made up 0.02% of Covestor's portfolio in Q2 2026, its #1090 holding.
  • Covestor first reported a position in 10x Genomics in Q4 2021 and has held it in 19 quarters since.
  • Covestor's 10x Genomics position peaked at $39K in Q1 2024.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.